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Abstract
Background: The World Health Organization estimated that 1.12 million children developed tuberculosis (TB) in
2018, and at least 200,000 children died from TB. Implementation of effective child contact management is an
important strategy to prevent childhood TB but these practices often are not prioritized or implemented,
particularly in low- and middle-income countries. This study aimed to explore attitudes of healthcare providers
toward TB prevention and perceived facilitators and challenges to child contact management in Lesotho, a high TB
burden country. Qualitative data were collected via group and individual in-depth interviews with 12 healthcare
providers at five health facilities in one district and analyzed using a thematic framework.
Results: Healthcare providers in our study were interested and committed to improve child TB contact management
and identified facilitators and challenges to a successful childhood TB prevention program. Facilitators included:
provider understanding of the importance of TB prevention and enhanced provider training on child TB contact
management, with a particular focus on ruling out TB in children and addressing side effects. Challenges identified by
providers were at multiple levels -- structural, clinic, and individual and included: [1] access to care, [2] supply-chain
issues, [3] identification and screening of child contacts, and [4] adherence to isoniazid preventive therapy.
Conclusions: Given the significant burden of TB morbidity and mortality in young children and the recent
requirement by the WHO to report IPT initiation in child contacts, prioritization of child TB contact management is
imperative and should include enhanced provider training on childhood TB and mentorship as well as strategies to
eliminate challenges. Strategies that enable more efficient child TB contact management delivery include creating
standardized tools that facilitate the implementation, tracking, and monitoring of child TB contact management
coupled with guidance and mentorship from the district health management team. To tackle access to care
challenges, we propose delivering intensive community health education, conducting community screening more
efficiently using standardized tools, and facilitating access to services in the community.
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Background
The World Health Organization (WHO) estimated that
1.12 million children < 15 years of age developed tuber-
culosis (TB) in 2018, and at least 200,000 children died
from TB [1]. Infants, young children, and HIV-positive
children are at increased risk for developing TB follow-
ing infection with Mycobacterium tuberculosis [2, 3] and
have higher risk of severe TB disease and death than the
general adult population [3, 4]. Given the significant
burden of TB disease and mortality in young children,
implementation of effective child TB contact manage-
ment (CCM) is an important upstream strategy to pre-
vent TB in children and also provides an opportunity for
early case detection and TB treatment initiation. Isonia-
zid preventive therapy (IPT) has been found to decrease
the risk of TB disease in children by 59% [5], and TB
screening and IPT in young children have been shown
to be highly cost-effective [6]. In 2006, the WHO pub-
lished the first guidelines for the management of child
TB contacts, recommending that national TB control
programs conduct contact investigations for TB and
offer IPT for child contacts < 5 years of age and for HIV-
positive child contacts of any age [7, 8]. Ten years later,
in 2016, the WHO added IPT initiation in child contacts
< 5 years of age as a formal indicator of TB program
performance [9]. Unfortunately while sub-Saharan Africa
has the highest childhood TB mortality rates, it has the
lowest proportion of child contacts < 5 years of age who
received IPT [1, 10]. While many national TB programs
have adopted the WHO guidelines, implementation of
these guidelines in high TB burden countries remains
limited with many countries experiencing operational
challenges [11, 12], which ultimately result in poor IPT
initiation and completion rates [13].
Lesotho is a lower middle-income sub-Saharan African
country [14], with an estimated TB incidence of 611 per
100,000 and HIV prevalence of 25.6%, the highest and sec-
ond highest rates in the world respectively [1, 15]. Child-
hood TB in Lesotho is largely managed by TB clinic nurses
in health facilities. Nurses provide outpatient care and pre-
ventive services and refer complicated cases to district hospi-
tals. Typically each TB clinic is staffed by one to three
nurses and one or two lay counselors, who are supported by
20–30 community-based village health workers (VHWs).
VHWs are charged with conducting contact investigation in
the community. The Ministry of Health (MOH) supplies
each health facility with isoniazid 100mg tablets for the
prevention of TB in child contacts as per standard of care;
isoniazid suspension is not available in Lesotho.
Childhood TB disease is likely to be underdiagnosed
and under-reported as only 4% of reported TB cases in
Lesotho are in children < 15 years [1], on the lower end
of the expected 10–20% in similar settings [16]. This
lower than expected reporting of pediatric cases is most
likely due to underdiagnosis of TB in children in
Lesotho. In 2011, the Lesotho National TB Program
(NTP) adopted the WHO’s recommendations for CCM,
but implementation has been limited and the reasons for
this wide policy-practice gap in this high TB burden con-
text are unclear. As healthcare providers are gatekeepers of
CCM implementation, we explored their attitudes toward
TB prevention in children and perceived facilitators and
challenges to CCM via qualitative interviews.
Methods
Study design, setting and population
We conducted interviews with healthcare providers as
part of formative research to inform intervention tool de-
velopment in our subsequent cluster randomized trial
[17]. In collaboration with the Ministry of Health, a single
district was chosen for conduct of the trial in order to en-
hance internal validity and maximize implementation cost
efficiency. Berea District was chosen because it was one of
the highest TB burden districts and there were no inter-
ventions addressing children’s needs in the district. Ten of
the 19 public health facilities in Berea district, Lesotho,
were randomized to deliver a community-based interven-
tion or standard of care, following stratification by facility
type. The remaining nine health facilities were excluded
from the sampling frame because of low TB patient case
load (on average, < 6 TB patients notified per quarter).
Both hospitals (N = 2) and health centers (N = 8) were in-
cluded to enhance generalizability of study findings as TB
services are provided in both types of facilities in Lesotho.
We chose to focus on healthcare providers from the five
health facilities that were randomized to deliver the study
intervention so as to obtain their feedback on planned
intervention components, especially their perceptions of
facilitators and challenges to SOC. A sample of 12 health-
care providers was recruited in December 2015, prior to
the launch of the cluster randomized trial. The five partici-
pating health facilities included one hospital and four
health centers. One of the four participating health centers
was located in a rural area whereas the other facilities
were located in urban areas. During the study period, we
enrolled a purposive sample of nine nurses who were the
main providers of TB care and all three facility-based lead
village health workers (LVHW) who were already
employed by the study at that time; all study participants
worked in a TB clinic. The main TB providers were tar-
geted by scheduling the interviews ahead of time when
they were scheduled to be at the health facility. However,
if one of the nurses was unexpectedly unavailable at the
scheduled time, we proceeded with the group interview.
Nurse participants had standard of care training on TB
provided by the Lesotho MOH. LVHW were originally
community-based VHWs, who were promoted to LVHW.
As community-based VHWs, they underwent the
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standard MOH training that focused on contact tracing.
Inclusion criteria were: nurse or LVHW working in a
study site; aged 18 or older; English- or Sesotho-speaking;
and capacity and willingness to provide informed consent.
All individuals approached for the study agreed to
participate. Four group interviews with nurses and four
individual interviews were completed with 12 providers,
including nine nurses and three LVHW. The majority
(11/12) of participants were female and the mean age
was 42 years (range 27–66). Interview duration ranged
from 25 to 55min, with a mean of 37 min.
Procedures
Four small group interviews were conducted with nurse
participants assigned to the same health facility due to
logistical reasons such as scheduling, illnesses, unexpected
rotations; these were similar to focus group discussions
but with a smaller number of participants, capitalizing on
group dynamics to capture group norms and experiences.
One individual interview was conducted with a nurse at
one facility because a group interview was not feasible due
to scheduling constraints. Three individual interviews
were also conducted with LVHW at three health facilities.
Participants were not compensated for participation as
per MOH policy but received a snack and fizzy drink.
The study was presented to nurses and LVHW at a
district-wide meeting prior to study launch. The trained
qualitative interviewer introduced the study to potential
participants at each facility as an exploration of their
views on CCM and if they were interested, obtained in-
formed consent. Interviews were conducted in English
or Sesotho at each participating health facility in a pri-
vate space on-site. The interview guide consisted of
open-ended, exploratory questions that were asked in a
non-judgmental and culturally-sensitive way. Respect for
participants’ privacy and confidentiality was emphasized
in group interviews, and divergent perspectives were
encouraged. Interviews were audio-recorded, transcribed
verbatim, translated, anonymized and subjected to text-
ual analysis. Study findings were presented and discussed
with participants at a district-wide meeting in 2016.
Quality assurance
We included several layers of quality assurance monitor-
ing to ensure the integrity of the qualitative interviews.
First, the Principal Investigator (YH-M) of this study has
considerable experience in developing interview guides
and supervising qualitative interviewers. Moreover, she
regularly consulted with researchers who have decades
of experience with qualitative interviewing (JEM). Sec-
ond, the interviewer’s experience as a research nurse in
other qualitative studies over the prior 4 years provided
her with vast experience and expertise in qualitative inter-
viewing. In addition, the interviewer participated in four
qualitative interview training sessions for this study. Fi-
nally, the interviewer was closely supervised in conducting
these interviews and was provided with timely feedback.
Domains
We developed an interview guide and pilot tested it
with study staff before study implementation. Ques-
tions relevant to this analysis addressed training re-
ceived on childhood TB and CCM and the need for
further training; attitudes toward CCM, including com-
munity screening, clinic evaluation, and IPT provision;
CCM challenges and possible solutions; and stigma in
the community (see Supplementary Material).
Analysis
Study investigators trained in qualitative analysis used the-
matic analyses as the framework for data inquiry and ana-
lysis. We used an iterative analytic process to facilitate a
comprehensive understanding of healthcare providers’
perspectives. Initially, we used deductive analysis to iden-
tify thematic categories based on our questions and the
CCM literature and inductive analysis to generate new
codes that emerged from the data. Two study investigators
(YH-M, LL) independently reviewed four transcripts (i.e.,
double-coded) to develop a preliminary coding scheme.
We used a “negotiated agreement approach” to ensure
consistent interpretation and application of codes, which
increases coding reliability [18, 19]. Differences in coding
were discussed and consensus reached on how to apply
codes. Once consensus on codes was achieved, the final
coding scheme was applied to the full set of transcripts.
Coding of the remaining transcripts was done independ-
ently by the two coders, but they continued to meet regu-
larly to discuss interpretation and application of the codes.
Typical quotations are used to illustrate the themes. We
used Dedoose (v. 6.2.17), a qualitative software program,
for systematic data management and analysis (Socio-Cul-
tural Research Consultants, LLC; Los Angeles, CA) [20].
Ethical considerations
The study was approved by the Columbia University Irving
Medical Center Institutional Review Board (Ref #IRB-
AAAN7358) and the National Health Research Ethics
Committee in Lesotho (Ref #ID78–2015). The overall
study was registered at ClinicalTrials.gov (NCT02662829).
All participants provided written informed consent prior to
study participation.
Results
Facilitators of a successful childhood TB prevention program
Provider understanding of the importance of TB preven-
tion and receiving enhanced provider training on CCM
were the major themes regarding a successful childhood
TB prevention program. Providers in this study agreed
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that TB prevention services, including contact tracing,
early detection of child TB contacts, and provision of
IPT to eligible children, are essential to controlling the
TB epidemic in Lesotho. They emphasized the import-
ance of IPT in confronting TB and spoke of the deleteri-
ous consequences of TB and the value of the protection
that IPT confers to children exposed to TB. Some of the
providers believed that CCM is feasible in Lesotho and
suggested expanding IPT to all household contacts of
TB cases and not just to children.
I see IPT … as a weapon that will protect children.
[LVHW, individual interview].
It [IPT] is good so that they can be safe and
protected … all children in their [household]
should be put on preventive therapy … [LVHW,
individual interview].
It [CCM] prevents spread of TB, eh, because if we
are targeting children … it is easier for them to catch
the disease … so if they are being targeted, to be
screened or to be supplied with isoniazid for 6 months,
I think it will help us control the disease and reduce
number of TB cases. [Nurse, individual interview].
IPT, if it can be given to every contact in the house
… everybody that we screened in that house found
with no TB should get on IPT. [LVHW, individual
interview].
Providers reported that having enhanced training on
CCM, including an emphasis on ruling out TB disease in
child contacts, is imperative. They were especially con-
cerned about missing cases of child TB disease and
wanted to know more about managing potential side ef-
fects from isoniazid (INH).
I think when we have engaged in trainings, it is then
that … we are able to attend to side effects … as
early as possible. Then we will be equipped with
skills … what are the complaints that might come
up, those that we are able to identify earlier. [Nurse,
group interview].
It is difficult to diagnose children, because if you are
going to start IPT without any X-ray or sputum
samples, we only base ourselves on signs and
symptoms … not knowing in depth what is
happening to the child. [Nurse, group interview].
We compared attitudes of nurses and LVHW and did
not discern any meaningful differences between the two
cadres regarding facilitators of a successful program.
Challenges to CCM provision and strategies for
addressing them
Providers reported multiple challenges to CCM provision
and suggested strategies for addressing them. Four themes
emerged from the interviews: limited access to care,
supply-chain issues, barriers to identification and screen-
ing of child contacts, and difficulty with IPT adherence.
Limited access to care
Providers reported that caregivers’ ability to bring children
to health facilities for CCM was a challenge. In some vil-
lages, community-based village health workers (CB-VHW)
provide child-related services, such as weighing children.
Expanding such community-based services by VHW to in-
clude screening and follow-up of child contacts was viewed
as potentially advantageous, especially for those experiencing
long or difficult journeys to the health facility and in situa-
tions where caregivers lack the resources to bring the chil-
dren for monthly follow-up appointments if IPT is initiated.
At times it is because these … [caregivers] come from
far remote areas where transport issues hinder them
from making several trips to the clinic.
[LVHW, individual interview].
They will tell you that they walk long distances, so
they cannot carry children from that far. [LVHW,
individual interview].
Supply-chain issues
Providers reported stock-outs and shortages of pediatric
formulations of INH and vitamin B6, which make it diffi-
cult for them to provide IPT to children. Having to adjust
adult doses to pediatric ones can be challenging as the
INH pills have to be cut in two or four depending on the
child’s weight. They indicated that availability of a reliable
drug supply would facilitate IPT implementation.
The challenges are … inconsistent supply of
appropriate drugs. [Nurse, individual interview].
It becomes very difficult for us. It [INH] takes a long
time to be replaced. Also, to reduce the adult dose
for children is so difficult. [Nurse, group interview].
Identification and screening of child contacts
Providers believed that identifying and screening chil-
dren for TB was the main challenge and that once
children come to the clinic, providing IPT is feasible.
Community education and the CB-VHW were seen as
pivotal to supporting caregivers to bring their children
to the clinic for evaluation.
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The problem is contacting or tracing of contacts. But
those who have been inside here, there are no
problems. [Nurse, group interview].
I usually ask the parent to come so that we have a
one-on-one health talk so that I explain clearly the
benefits of getting into the preventive therapy and
the risks of denying this therapy. So with persuasion,
we see some do bring their children, but some are
just hard-hearted and they don’t. [Nurse, individual
interview].
In cases where caregivers do not bring in the child
contacts for evaluation, CB-VHW are deployed to assist,
and when they have difficulty tracing patients, the village
chief is informed so that he can assist in finding them.
We use our CB-VHW to help us bring them. Those are
the ones who assist us most of the time. [Nurse, group
interview].
If they [CB-VHW] are unable to find and bring
them, then we inform the village chief that we have
a TB patient in his village and that we need [to
assess] their children. [Nurse, group interview].
Nurses and LVHW emphasized the need for health
education as they believed that community members do
not recognize the importance of preventing TB in child
contacts, including the need for infection control in situ-
ations where a presumptive or confirmed TB case has
been identified in the household. Providers suggested
that community-based health education can reach more
people and have a greater impact, especially by strength-
ening the role of CB-VHW to educate families in the
community.
We have to educate them … so that they understand
why, because then if while a child is on IPT, it
means it is a long period of time. [Nurse, group
interview].
There is a need to go out to schools, during public
gatherings, wherever we are able to go and reach
out to provide health education. [Nurse, group
interview].
We also ask the CB-VHW to give the health education
at the village so that the parent will end up
understanding that it is important to have the
children on IPT. [Nurse, group interview].
IPT adherence
Providers indicated that IPT adherence was another
major challenge, possibly because of fear of the drug’s
side effects such as a severe rash. To tackle this issue,
they suggested continuous enhancement of health liter-
acy for caregivers about the importance of adherence
and the possibility of side effects from IPT.
The challenge is the child cannot come regularly.
She comes once, skips a month. When you follow the
child again, the child reappears so there is drug
interruption. [Nurse, individual interview].
The challenge is that we find later after they have
missed doses of IPT because of experiencing side
effects. [Nurse, group interview].
When we compared attitudes of nurses and LVHW re-
garding challenges to CCM, LVHW were more focused
on issues of access-to-care whereas nurses were more
concerned about supply-chain issues.
Perceived stigma
Stigma was not reported as a CCM challenge. When pro-
viders were specifically questioned about the role that
stigma plays, they indicated that stigma related to TB
prevention is generally not perceived as an issue in the
community. However, some providers acknowledged that
stigma may play a role in some situations where caregivers
did not bring children to the clinic. Others believed that
lack of knowledge, not stigma, is the reason that caregivers
did not bring children to the clinic. Providers felt that com-
munity health education campaigns could help to increase
knowledge regarding TB and dispel any possible stigma.
TB these days is no longer stigmatized; everybody is
willing … so they do not have a problem if you want
to screen them in the community. [Nurse, group
interview].
Not stigma as such, lack of knowledge maybe … I
don’t think stigma is still a problem.
[Nurse, individual interview].
It [IPT] won’t put them at risk of stigma because
they would have accepted that their children should
be initiated [on IPT]. [LVHW, individual interview].
Those who are bringing their children do not have
the problem [stigma], but I could see or sense that
these ones who don’t want to bring in their children,
they think in some way of stigma. [Nurse, individual
interview].
Discussion
In this manuscript, we report on healthcare providers’
perceptions of facilitators and challenges. These data
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were collected as part of formative research in pre-
paration for our subsequent cluster randomized trial. A
limited number of studies have explored provider atti-
tudes regarding TB prevention in children in a high TB
burden setting in-depth [13]. In this qualitative study,
we found interest and commitment among healthcare
providers in Lesotho to improve CCM. Providers re-
ported a need to have enhanced training on CCM, with
an emphasis on ruling out TB disease among child con-
tacts and advocated for strong community health educa-
tion efforts as they reported that community members
do not currently recognize the importance of preventing
TB in child contacts. Such efforts would enable care-
givers of TB child contacts to appreciate the importance
of preventing TB in such children and the role that TB
prevention can play in their children’s health and well-
being.
The challenges identified in this study suggest the
primary drivers that need to be addressed to achieve
successful TB prevention in children in Lesotho, sum-
marized in the driver diagram in Fig. 1. We identified
that prohibitive cost of transport and long and difficult
journeys to the clinic were structural challenges to
CCM. This is similar to findings from other studies that
employed qualitative methods and reported costs and
transportation challenges as major barriers [21–26]. Pro-
viders in our study suggested strategies to decrease costs
to caregivers, such as home visits that include weighing
children so that INH dosages can be adjusted according
to the child’s weight, precluding the need for caregivers
to bring children to the clinic every month. Another
structural challenge to IPT delivery was the lack of reli-
able supply of pediatric formulation of INH and vitamin
B6, an issue that has been reported in prior studies [21,
27, 28]. Although according to the Lesotho NTP guide-
lines, vitamin B6 is recommended to be given with INH,
nurses are encouraged to prescribe INH even in the case
of vitamin B6 shortage as peripheral neuropathy is un-
common in young children [29]. It is unclear whether
the INH stock-outs and shortages are due to procure-
ment problems or inefficient distribution of the supply
of the drug to health facilities. It is also possible that the
shortage may be due to inaccurate forecasting of the
required doses of INH and vitamin B6 that are needed.
Identification and screening of child contacts was found
to be a clinic-level challenge that affects the success of TB
prevention efforts. Lack of community contact tracing
follow-up contributed to this challenge. These challenges
likely arose from gaps in caregiver education about the
importance of TB prevention, which has been reported in
other studies [21, 23, 26, 27, 30, 31]. Providers recom-
mended that caregivers be educated in the community by
CB-VHW so that they will be convinced of the need to
have their children evaluated. Additionally, the Lesotho
TB program has had some success involving the village
chiefs in motivating reluctant caregivers to take their
children for evaluation at the health facilities.
IPT adherence was an individual-level barrier to CCM,
with providers reporting that caregivers may not fully
understand the importance of adherence and worry
about possible side effects from IPT. Caregiver concerns
about side effects have been reported in studies from
India and Indonesia [22–24, 27]. Providers suggested
that health literacy education about the importance of
adherence with IPT and possible side effects might
encourage caregivers to more promptly present at the
Fig. 1 Driver Diagram for CCM in Lesotho
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health facilities if their children demonstrate either of
these. This might also alleviate the failure to complete
IPT course by children that may be due to side effects
experienced by the children.
While providers did not perceive stigma as an import-
ant issue in the community as related to TB and IPT
when specifically questioned, some acknowledged that it
may play a role in situations where caregivers failed to
bring children to the clinic. Skinner et al. similarly found
that providers felt that TB was so widely prevalent that
it could no longer be stigmatized. The role of stigma
needs to be further explored among caregivers of child
TB contacts [31].
Our qualitative evaluation had several limitations.
Given the small sample of providers drawn from a small
number of health facilities, the findings may not reflect
the experiences of all healthcare providers engaged in
public-sector TB care in Lesotho, limiting our ability to
draw definitive conclusions about CCM and IPT. We
conducted provider interviews at five health facilities in
a combination of small group and individual interviews
and were limited to those providers who worked at those
facilities and were available on the interview day. Our
sample is relatively homogenous --study participants are
well positioned to reflect on study topics, work for the
MOH and all were exposed to the basic MOH training
on TB. The interviewer’s familiarity with the healthcare
providers in study facilities may have led to either more
honest discussions or socially desirable responses.
Nevertheless, the study also had several strengths. Our
qualitative study explored provider attitudes in-depth,
thereby providing rich data collected in a rigorous way as
we included several layers of quality assurance monitoring
to ensure the integrity of the qualitative interviews. Inter-
pretations were contextualized with illustrative quotes to
enhance their applicability and relevance to similar high
TB burden settings. Our sample included both nurses and
LVHW, who were able to provide different perspectives
on challenges, with LVHW focusing on issues of access-
to-care and nurses expressing concerns about supply-
chain issues. Few studies conducted to date employed
qualitative methods to explore in-depth provider attitudes
toward TB prevention in high TB burden settings, and
only two of these qualitative evaluations were conducted
in sub-Saharan Africa [21, 31].
Conclusions
Despite a decade-long recommendation from the WHO
to conduct CCM in high TB burden settings, its imple-
mentation in Lesotho has been limited. However, we
found interest and commitment among TB providers in
our study to improve CCM. Challenges identified by
providers were at multiple levels -- structural, clinic, and
individual. Given the significant burden of TB morbidity
and mortality in young children and the recent require-
ment by the WHO to report IPT initiation in child con-
tacts, prioritization of CCM is imperative and should
include enhanced provider training on childhood TB
and CCM and mentorship as well as strategies to elimin-
ate challenges. Strategies that enable a more efficient
CCM delivery include creating standardized tools that
facilitate the implementation, tracking, and monitoring
of child TB contact management coupled with guidance
and mentorship from the district health management
team. To tackle access to care challenges, we propose
delivering intensive community health education, con-
ducting community screening more efficiently using
standardized tools, and facilitating access to services in
the community.
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